Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Acorda Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −1 vs. Q2 2021
- Shares held
- 3.20M
- −582.8K (−15.4%) vs. Q2 2021
- Total value
- $14.7M
- −$3.33M (−18.4%) vs. Q2 2021
- New holders
- 5
- 9 more added
- Sold out
- 6
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 2 | $8.00K |
| Q1 2024 | 17 | $2.13M |
| Q4 2023 | 15 | $2.33M |
| Q3 2023 | 16 | $2.30M |
| Q2 2023 | 15 | $1.94M |
| Q1 2023 | 30 | $3.71M |
| Q4 2022 | 36 | $4.09M |
| Q3 2022 | 36 | $1.91M |
| Q2 2022 | 35 | $3.08M |
| Q1 2022 | 34 | $5.42M |
| Q4 2021 | 34 | $9.48M |
| Q3 2021 | 36 | $14.7M |
| Q2 2021 | 37 | $18.1M |
| Q1 2021 | 37 | $18.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Acorda Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 8 | $0 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 50 | $0 | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| IMA Wealth, Inc. | 17 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6 | $0 | 0.00% | −94−94.0% | Reduced |
| Cutler Group LP | 117 | $0 | 0.00% | 00.0% | Unchanged |
| JNBA Financial Advisors | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 85 | $0 | 0.00% | +1+1.2% | Added |
| Royal Bank of Canada | 251 | $1.00K | 0.00% | −194−43.6% | Reduced |
| Wells Fargo & Company | 192 | $1.00K | 0.00% | −3−1.5% | Reduced |
| Morgan Stanley | 4,024 | $19.0K | 0.00% | −18,411−82.1% | Reduced |
| UBS Group AG | 4,486 | $20.0K | 0.00% | +4,427+7,503.4% | Added |
| Russell Investments Group, Ltd. | 6,000 | $27.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 10,855 | $50.0K | 0.00% | +10,855 | New |
| Two Sigma Advisers, LP | 12,000 | $55.0K | 0.00% | +12,000 | New |
| Apollon Wealth Management, LLC | 15,000 | $69.0K | 0.01% | +15,000 | New |
| Bank of America Corp | 19,427 | $89.0K | 0.00% | +19,250+10,875.7% | Added |
| Susquehanna Fundamental Investments, LLC | 23,800 | $109.0K | 0.00% | +23,800 | New |
| Blair William & Co | 23,840 | $110.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,613 | $123.0K | 0.00% | −2,588−8.9% | Reduced |
| United Asset Strategies, Inc. | 27,100 | $125.0K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 31,648 | $146.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 35,850 | $165.0K | 0.00% | −4,815−11.8% | Reduced |
| AE Wealth Management LLC | 40,457 | $186.0K | 0.00% | +40,457 | New |
| Millennium Management LLC | 40,721 | $187.0K | 0.00% | +7,432+22.3% | Added |
| Dimensional Fund Advisors LP | 41,856 | $193.0K | 0.00% | −35,552−45.9% | Reduced |
| Geode Capital Management, LLC | 46,721 | $214.0K | 0.00% | −26,841−36.5% | Reduced |
| Invesco Ltd. | 82,911 | $381.0K | 0.00% | +2,904+3.6% | Added |
| Federated Hermes, Inc. | 98,485 | $453.0K | 0.00% | −6,331−6.0% | Reduced |
| Bridgeway Capital Management, LLC | 140,590 | $647.0K | 0.01% | +39,000+38.4% | Added |
| BlackRock Inc. | 161,939 | $744.0K | 0.00% | −5,310−3.2% | Reduced |
| Vanguard Group Inc | 341,545 | $1.57M | 0.00% | +1,064+0.3% | Added |
| Acadian Asset Management LLC | 382,404 | $1.76M | 0.01% | +2,482+0.7% | Added |
| Canyon Capital Advisors LLC | 392,904 | $1.81M | 0.06% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 468,166 | $2.15M | 0.01% | −420,733−47.3% | Reduced |
| Renaissance Technologies LLC | 724,718 | $3.33M | 0.00% | +10,600+1.5% | Added |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −135,190−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −49,269−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −44,666−100.0% | Sold out |
| HN Saltoro Capital, LP | 0 | $0 | 0.00% | −11,853−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,119−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −67−100.0% | Sold out |